Gamida Cell Ltd. Careers, Jobs, and Salary Information

Gamida Cell Ltd. is a clinical-stage biotechnology company that is engaged in developing cell therapies that are designed to cure cancer and rare, serious hematologic diseases. The company's proprietary nicotinamide-, or NAM-, based cell expansion technology, known as NAM-enabled cell therapy, is designed to expand a single umbilical cord blood-derived stem cell into hundreds of millions of cells. Gamida Cell's pipeline includes two clinical-stage product candidates: NiCord and NAM-NK. NiCord is a cell therapy that is designed to expand hematopoietic stem/progenitor cells from cord blood in culture and then transplant them in patients with hematologic malignancies. NAM-NK is a cell therapy that is designed to improve the anti-tumor activity of natural killer cells. Gamida Cell is headquartered in Jerusalem, Israel.